221 related articles for article (PubMed ID: 23139233)
21. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
23. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
Li YQ; Yu QM; Li J; Yang JR; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
[TBL] [Abstract][Full Text] [Related]
25. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of and factors associated with increased arterial stiffness in patients with primary Sjögren's syndrome.
Sabio JM; Sánchez-Berná I; Martinez-Bordonado J; Vargas-Hitos JA; Navarrete-Navarrete N; Expósito Ruíz M; Jiménez-Alonso J
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):554-62. PubMed ID: 25303669
[TBL] [Abstract][Full Text] [Related]
27. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
[TBL] [Abstract][Full Text] [Related]
28. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
[TBL] [Abstract][Full Text] [Related]
29. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of primary Sjögren's syndrome in China.
Zhang NZ; Shi CS; Yao QP; Pan GX; Wang LL; Wen ZX; Li XC; Dong Y
J Rheumatol; 1995 Apr; 22(4):659-61. PubMed ID: 7791159
[TBL] [Abstract][Full Text] [Related]
31. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
32. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
33. Primary Sjogren's syndrome: rarity in India.
Misra R; Hissaria P; Tandon V; Aggarwal A; Krishnani N; Dabadghao S
J Assoc Physicians India; 2003 Sep; 51():859-62. PubMed ID: 14710969
[TBL] [Abstract][Full Text] [Related]
34. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
[TBL] [Abstract][Full Text] [Related]
35. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
[TBL] [Abstract][Full Text] [Related]
36. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
37. Classification criteria for Sjogren's syndrome: a critical review.
Baldini C; Talarico R; Tzioufas AG; Bombardieri S
J Autoimmun; 2012 Aug; 39(1-2):9-14. PubMed ID: 22209352
[TBL] [Abstract][Full Text] [Related]
38. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort.
Maciel G; Crowson CS; Matteson EL; Cornec D
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1612-1616. PubMed ID: 27998024
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
